抗髓相关的糖蛋白神经病变:最近的发展
Jennifer Morganroth1, Chafic Karam1
1Department of Neurology, University of Pennsylvania.
Neurology. Clinical practice
|October 14, 2024
概括
最近在抗髓相关的葡萄糖蛋白 (MAG) 神经病变中的发现表明,抗MAG水平的50%降低与治疗反应相关. 本综述更新了这种异质疾病的诊断,预后和治疗方法.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 骨髓相关葡萄糖蛋白 (MAG) 神经病变是一种罕见的自身免疫性疾病,影响了外围神经.
- 了解疾病的异质性和自然史对于有效管理至关重要.
研究的目的:
- 为提供有关髓相关葡萄糖蛋白 (MAG) 神经病变的最新综述.
- 突出了解和治疗抗MAG神经病的最新进展.
主要方法:
- 对50项针对抗MAG神经病的临床试验的回顾性分析.
- 关于诊断标准,预后因素和治疗反应的最新文献的审查.
主要成果:
- 抗MAG抗体水平减少至少50%与积极的治疗反应有关.
- 针对诊断,治疗反应和恶化的抗体水平的最新见解.
- 鉴定与恶性瘤相关的特定抗体类型.
结论:
- 抗MAG神经病变是一种复杂的疾病,具有不断变化的诊断和预后标志物.
- 正在开发治疗策略,特别是针对耐火性疾病患者.
- 需要进一步的研究来完善治疗方法和了解疾病机制.
更多相关视频
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
10.9K
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
16.2K
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Myasthenia Gravis: Diagnostic Tests
686
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
686
